For example, Bagger et al. [66] demonstrated that intravenous (IV) glucose administration did not reduce glucagon levels in subjects with T2DM; however, it was achieved with oral glucose administration, suggesting a potential role of intestine lining and incretins on α cell. The gene discussed is GCG; the disease is type 2 diabetes mellitus.